Clinical instruments used within Kivira

Kivira uses validated clinical instruments and questionnaires to support structured assessment and symptom monitoring. Not all instruments are used at any one time. Which scales are presented can depend on a patient’s earlier responses, clinical context, and configured workflows. Kivira's current patient-facing workflow is intended for adults age 18 and older. These tools are intended to support care, not to replace a clinician’s judgment or provide a diagnosis by themselves.

Back to kivira.health Jump to references

Instrument list

0 instruments
Note: This page lists instrument names, what they assess, and primary references. It does not reproduce questionnaire items.
Scale What it assesses Commonly used for Refs

References

Primary sources
  1. Galvin JE, Roe CM, Powlishta KK, et al. The AD8: a brief informant interview to detect dementia. Neurology. 2005;65(4):559-564. doi:10.1212/01.wnl.0000172958.95282.2a. PubMed: 16116116
  2. Altman EG, Hedeker D, Peterson JL, Davis JM. The Altman Self-Rating Mania Scale. Biol Psychiatry. 1997;42(10):948-955. doi:10.1016/S0006-3223(96)00548-3. PubMed: 9359982
  3. Allison C, Auyeung B, Baron-Cohen S. Toward brief "Red Flags" for autism screening: The Short Autism Spectrum Quotient and the Short Quantitative Checklist in 1,000 cases and 3,000 controls [corrected]. J Am Acad Child Adolesc Psychiatry. 2012;51(2):202-212.e7. doi:10.1016/j.jaac.2011.11.003. PubMed: 22265366
  4. World Health Organization. Measuring health and disability: manual for WHO Disability Assessment Schedule (WHODAS 2.0). Geneva: World Health Organization; 2010. ISBN: 9789241547598.
  5. Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption-II. Addiction. 1993;88(6):791-804. doi:10.1111/j.1360-0443.1993.tb02093.x. PubMed: 8329970
  6. Skinner HA. The drug abuse screening test (DAST). Addict Behav. 1982;7(4):363-371. doi:10.1016/0306-4603(82)90005-3. PubMed: 7183189
  7. Spitzer RL, Kroenke K, Williams JBW, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092-1097. doi:10.1001/archinte.166.10.1092. PubMed: 16717171
  8. Kroenke K, Spitzer RL, Williams JBW. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606-613. doi:10.1046/j.1525-1497.2001.016009606.x. PubMed: 11556941
  9. Isidori AM, Pozza C, Esposito K, et al. Development and validation of a 6-item version of the Female Sexual Function Index (FSFI). J Sex Med. 2010;7(3):1139-1146. doi:10.1111/j.1743-6109.2009.01635.x. PubMed: 19968774
  10. Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology. 1997;49(6):822-830. doi:10.1016/S0090-4295(97)00238-0. PubMed: 9187685
  11. Morgan JF, Reid F, Lacey JH. The SCOFF questionnaire: assessment of a new screening tool for eating disorders. BMJ. 1999;319(7223):1467-1468. doi:10.1136/bmj.319.7223.1467. PubMed: 10582927
  12. Weathers FW, Litz BT, Keane TM, Palmieri PA, Marx BP, Schnurr PP. The PTSD Checklist for DSM-5 (PCL-5). National Center for PTSD; 2013.
  13. Mossaheb N, Becker J, Schaefer MR, Klier CM, Schloegelhofer M, Papageorgiou K, Amminger GP. The Community Assessment of Psychic Experience (CAPE) questionnaire as a screening-instrument in the detection of individuals at ultra-high risk for psychosis. Schizophr Res. 2012;141(2-3):210-214. doi:10.1016/j.schres.2012.08.008. PubMed: 22986044
  14. Bastien CH, Vallières A, Morin CM. Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Med. 2001;2(4):297-307. doi:10.1016/S1389-9457(00)00065-4. PubMed: 11438246
  15. Goodman WK, Price LH, Rasmussen SA, et al. The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Arch Gen Psychiatry. 1989;46(11):1006-1011. doi:10.1001/archpsyc.1989.01810110048007. PubMed: 2684084
  16. Houck PR, Spiegel DA, Shear MK, Rucci P. Reliability of the self-report version of the Panic Disorder Severity Scale. Depress Anxiety. 2002;15(4):183-185. doi:10.1002/da.10049. PubMed: 12112724
  17. Connor KM, Kobak KA, Churchill LE, Katzelnick D, Davidson JRT. Mini-SPIN: a brief screening assessment for generalized social anxiety disorder. Depress Anxiety. 2001;14(2):137-140. doi:10.1002/da.1055. PubMed: 11668666
  18. Kessler RC, Adler L, Ames M, et al. The World Health Organization Adult ADHD Self-Report Scale (ASRS): a short screening scale for use in the general population. Psychol Med. 2005;35(2):245-256. doi:10.1017/S0033291704002892. PubMed: 15841682
  19. National Institute of Mental Health. Ask Suicide-Screening Questions (ASQ) Toolkit: Adults ASQ Toolkit. NIMH
  20. Horowitz LM, Snyder DJ, Boudreaux ED, et al. Validation of the Ask Suicide-Screening Questions for Adult Medical Inpatients: A Brief Tool for All Ages. Psychosomatics. 2020;61(6):713-722. doi:10.1016/j.psym.2020.04.008. PubMed: 32487323

If you believe you may be in immediate danger or experiencing a medical emergency, contact local emergency services.